Literature DB >> 31392158

Looking into the clinical application of CD47-targeted near-infrared photoimmunotherapy for human bladder cancer treatment.

Jayoung Kim1,2,3.   

Abstract

Entities:  

Year:  2019        PMID： 31392158      PMCID： PMC6642946          DOI： 10.21037/tau.2019.05.13

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN： 2223-4683


× No keyword cloud information.
  13 in total

1.  High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: a study using formalin-fixed, paraffin-embedded archival tissues.

Authors:  Alcides Chaux; Julie S Cohen; Luciana Schultz; Roula Albadine; Sana Jadallah; Kathleen M Murphy; Rajni Sharma; Mark P Schoenberg; George J Netto
Journal:  Hum Pathol       Date:  2012-03-09       Impact factor: 3.466

2.  Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.

Authors:  Reema Railkar; L Spencer Krane; Q Quentin Li; Thomas Sanford; Mohammad Rashid Siddiqui; Diana Haines; Srinivas Vourganti; Sam J Brancato; Peter L Choyke; Hisataka Kobayashi; Piyush K Agarwal
Journal:  Mol Cancer Ther       Date:  2017-06-15       Impact factor: 6.261

3.  From patient to discoverer--Niels Ryberg Finsen (1860–1904) --the founder of phototherapy in dermatology.

Authors:  Andrzej Grzybowski; Krzysztof Pietrzak
Journal:  Clin Dermatol       Date:  2012 Jul-Aug       Impact factor: 3.541

Review 4.  Stimulation of anti-tumor immunity by photodynamic therapy.

Authors:  Pawel Mroz; Javad T Hashmi; Ying-Ying Huang; Norbert Lange; Michael R Hamblin
Journal:  Expert Rev Clin Immunol       Date:  2011-01       Impact factor: 4.473

5.  Expression of the epidermal growth factor receptor family in normal and malignant urothelium.

Authors:  Ranveig Røtterud; Jahn Marthin Nesland; Aasmund Berner; Sophie D Fosså
Journal:  BJU Int       Date:  2005-06       Impact factor: 5.588

Review 6.  Photodynamic Therapy in the Treatment of Bladder Cancer: Past Challenges and Current Innovations.

Authors:  Reema Railkar; Piyush K Agarwal
Journal:  Eur Urol Focus       Date:  2018-08-23

Review 7.  Super enhanced permeability and retention (SUPR) effects in tumors following near infrared photoimmunotherapy.

Authors:  Hisataka Kobayashi; Peter L Choyke
Journal:  Nanoscale       Date:  2015-10-07       Impact factor: 7.790

8.  O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia.

Authors:  Tingsheng Lin; Xiaozhi Zhao; Sheng Zhao; Hang Yu; Wenmin Cao; Wei Chen; Hui Wei; Hongqian Guo
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

9.  Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer.

Authors:  C Blick; A Ramachandran; S Wigfield; R McCormick; A Jubb; F M Buffa; H Turley; M A Knowles; D Cranston; J Catto; A L Harris
Journal:  Br J Cancer       Date:  2013-06-18       Impact factor: 7.640

10.  Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer.

Authors:  B A Hunter; A Eustace; J J Irlam; H R Valentine; H Denley; K K Oguejiofor; R Swindell; P J Hoskin; A Choudhury; C M West
Journal:  Br J Cancer       Date:  2014-06-17       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.